• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用宏基因组测序技术分析非结核分枝杆菌肺病患者的肺微环境

Lung Microenvironment Among Patients with Nontuberculous Mycobacterial Pulmonary Disease by Metagenomic Sequencing Technique.

作者信息

Qin Le, Chen Yu, Luan Sichun, Yin Xiaoyu, Pan Jue, Wang Leilei, Yao Yumeng, Zhou Chunmei, Bao Rong, Shen Jiajin, Miao Qing, Hu Bijie

机构信息

Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Shanghai Institute of Infectious Disease and Biosecurity, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

出版信息

Biomedicines. 2025 Mar 28;13(4):818. doi: 10.3390/biomedicines13040818.

DOI:10.3390/biomedicines13040818
PMID:40299453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12025003/
Abstract

: Nontuberculous mycobacterial pulmonary disease (NTM-PD) is an increasingly prevalent chronic infection, where the host immune status plays a crucial role in disease susceptibility and progression. The complex pulmonary microenvironment, characterized by diverse microbial communities and host immune interactions, exhibits distinct features that may be fundamentally altered by the patient's underlying immune state. : A total of 111 sputum specimens and 64 bronchoalveolar lavage fluid (BALF) specimens were collected from 143 patients diagnosed with NTM-PD under different immune states. Metagenomic sequencing was performed on these specimens to characterize and compare the pulmonary microenvironmental features among NTM-PD patients with a distinct immune status through comprehensive bioinformatic analyses. : The immunosuppressed group exhibited a lower α-diversity in sputum specimens ( < 0.05). Principal Coordinates Analysis (PCoA) of β-diversity for sputum and BALF specimens revealed significant differences between the groups ( < 0.05). Linear discriminant analysis Effect Size (LEfSe) analysis identified species enriched in the immunosuppressed group. A co-occurrence network analysis indicated that the immunosuppressed group had more structured and actively connected networks compared to the control group. The Mantel test confirmed that the abundance of these species enriched was associated with clinical immune-inflammation-related indicators in patients. : Our study reveals the pulmonary microenvironment in immunosuppressed patients with NTM-PD. Further work is required to explore the two-way relationship between micro-organisms and immune and inflammatory responses, with the influence on patient outcomes.

摘要

非结核分枝杆菌肺病(NTM-PD)是一种日益普遍的慢性感染,宿主免疫状态在疾病易感性和进展中起着关键作用。复杂的肺部微环境以多样的微生物群落和宿主免疫相互作用为特征,呈现出独特的特征,可能会因患者潜在的免疫状态而发生根本性改变。

共从143例处于不同免疫状态的NTM-PD确诊患者中收集了111份痰标本和64份支气管肺泡灌洗(BALF)液标本。对这些标本进行宏基因组测序,通过全面的生物信息学分析来表征和比较具有不同免疫状态的NTM-PD患者的肺部微环境特征。

免疫抑制组痰标本中的α多样性较低(<0.05)。对痰和BALF标本的β多样性进行主坐标分析(PCoA)显示,各组之间存在显著差异(<0.05)。线性判别分析效应大小(LEfSe)分析确定了免疫抑制组中富集的物种。共现网络分析表明,与对照组相比,免疫抑制组具有更多结构化且活跃连接的网络。Mantel检验证实,这些富集物种的丰度与患者临床免疫炎症相关指标有关。

我们的研究揭示了免疫抑制的NTM-PD患者的肺部微环境。需要进一步开展工作来探索微生物与免疫和炎症反应之间的双向关系及其对患者预后的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/5983b74ef4bb/biomedicines-13-00818-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/74252d482944/biomedicines-13-00818-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/c2d47c1b8115/biomedicines-13-00818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/0326fab1542a/biomedicines-13-00818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/6f7042841040/biomedicines-13-00818-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/5983b74ef4bb/biomedicines-13-00818-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/74252d482944/biomedicines-13-00818-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/c2d47c1b8115/biomedicines-13-00818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/0326fab1542a/biomedicines-13-00818-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/6f7042841040/biomedicines-13-00818-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/12025003/5983b74ef4bb/biomedicines-13-00818-g004.jpg

相似文献

1
Lung Microenvironment Among Patients with Nontuberculous Mycobacterial Pulmonary Disease by Metagenomic Sequencing Technique.采用宏基因组测序技术分析非结核分枝杆菌肺病患者的肺微环境
Biomedicines. 2025 Mar 28;13(4):818. doi: 10.3390/biomedicines13040818.
2
[Chinese expert consensus on diagnosis and treatment of non-tuberculous mycobacterial pulmonary disease complicated with bronchiectasis].《非结核分枝杆菌肺病合并支气管扩张症诊断与治疗中国专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Feb 12;48(2):101-115. doi: 10.3760/cma.j.cn112147-20240808-00471.
3
Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment.稳定非结核分枝杆菌肺病患者与需要治疗患者的痰微生物组比较。
BMC Microbiol. 2024 May 18;24(1):172. doi: 10.1186/s12866-024-03308-2.
4
Clinical Utility of Induced Sputum and Bronchoalveolar Lavage Cultures in Diagnosing Nontuberculous Mycobacterial Pulmonary Disease.诱导痰和支气管肺泡灌洗培养在诊断非结核分枝杆菌肺病中的临床应用
Pathogens. 2024 Dec 3;13(12):1064. doi: 10.3390/pathogens13121064.
5
The value of gene chip detection of bronchoalveolar lavage fluid in the diagnosis of nontuberculous mycobacterial lung disease.支气管肺泡灌洗液基因芯片检测在非结核分枝杆菌肺病诊断中的价值
Ann Palliat Med. 2021 Jun;10(6):6438-6445. doi: 10.21037/apm-21-1205. Epub 2021 Jun 21.
6
Microbiome Diversity in Sputum of Nontuberculous Mycobacteria Infected Women with a History of Breast Cancer.有乳腺癌病史的非结核分枝杆菌感染女性痰液中的微生物群多样性
Cell Physiol Biochem. 2019;52(2):263-279. doi: 10.33594/000000020. Epub 2019 Feb 28.
7
Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study.采用两种方法诊断非结核分枝杆菌肺病:一项前瞻性队列研究。
BMC Infect Dis. 2019 May 24;19(1):468. doi: 10.1186/s12879-019-4078-0.
8
The First Case Report of Inactive Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) in a Pneumoconiosis Patient Caused by in China.中国首例由[具体病因未给出]引起的尘肺病患者非活动性非结核分枝杆菌肺病(NTM-PD)病例报告 。
Infect Drug Resist. 2024 Apr 16;17:1515-1521. doi: 10.2147/IDR.S448805. eCollection 2024.
9
Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment.对分枝杆菌(NTM)肺病共患患者痰液标本中的分枝杆菌分离株和环境中的分枝杆菌分离株进行全基因组测序。
BMC Genomics. 2020 Apr 23;21(1):322. doi: 10.1186/s12864-020-6738-2.
10
Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者的肺部和肠道微生物群多样性减少。
Korean J Intern Med. 2023 Nov;38(6):879-892. doi: 10.3904/kjim.2023.097. Epub 2023 Oct 23.

引用本文的文献

1
The gut-lung axis and microbiome dysbiosis in non-tuberculous mycobacterial infections: immune mechanisms, clinical implications, and therapeutic frontiers.非结核分枝杆菌感染中的肠-肺轴与微生物群失调:免疫机制、临床意义及治疗前沿
Gut Pathog. 2025 Jun 6;17(1):40. doi: 10.1186/s13099-025-00718-z.

本文引用的文献

1
Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.非结核分枝杆菌肺病:患者、原则与展望。
Clin Infect Dis. 2024 Oct 15;79(4):e27-e47. doi: 10.1093/cid/ciae421.
2
Enhanced diagnosis of pulmonary tuberculosis through nucleotide MALDI-TOF MS analysis of BALF: a retrospective clinical study.通过支气管肺泡灌洗液的核苷酸基质辅助激光解吸电离飞行时间质谱分析增强肺结核诊断:一项回顾性临床研究
Sci Rep. 2024 Aug 8;14(1):18416. doi: 10.1038/s41598-024-66178-8.
3
Wekemo Bioincloud: A user-friendly platform for meta-omics data analyses.
Wekemo生物云平台:一个便于用户使用的元组学数据分析平台。
Imeta. 2024 Feb 13;3(1):e175. doi: 10.1002/imt2.175. eCollection 2024 Feb.
4
Lung microbiome: new insights into the pathogenesis of respiratory diseases.肺部微生物组:呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
5
Interkingdom interactions between Pseudomonas aeruginosa and Candida albicans affect clinical outcomes and antimicrobial responses.铜绿假单胞菌和白色念珠菌之间的跨界相互作用会影响临床结果和抗菌反应。
Curr Opin Microbiol. 2023 Oct;75:102368. doi: 10.1016/j.mib.2023.102368. Epub 2023 Sep 6.
6
Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing.非结核分枝杆菌肺病患者的临床特征:一项在北京某三甲医院进行的为期七年的随访研究。
Front Cell Infect Microbiol. 2023 Jun 22;13:1205225. doi: 10.3389/fcimb.2023.1205225. eCollection 2023.
7
Impact of prophylactic and 'rescue pack' antibiotics on the airway microbiome in chronic lung disease.预防性和“救援包”抗生素对慢性肺病患者气道微生物组的影响。
BMJ Open Respir Res. 2023 Apr;10(1). doi: 10.1136/bmjresp-2022-001335.
8
Non-Tuberculous Mycobacteria and Lung Co-Infection: Systematic Review.非结核分枝杆菌与肺部合并感染:系统评价
J Clin Med. 2022 Sep 23;11(19):5619. doi: 10.3390/jcm11195619.
9
Profiles of Microbial Community and Antibiotic Resistome in Wild Tick Species.野生蜱物种中的微生物群落和抗生素抗性组特征。
mSystems. 2022 Aug 30;7(4):e0003722. doi: 10.1128/msystems.00037-22. Epub 2022 Aug 1.
10
Clinical Characteristics and Mortality of Non-tuberculous Mycobacterial Infection in Immunocompromised vs. Immunocompetent Hosts.免疫功能低下与免疫功能正常宿主中非结核分枝杆菌感染的临床特征及死亡率
Front Med (Lausanne). 2022 May 18;9:884446. doi: 10.3389/fmed.2022.884446. eCollection 2022.